Developing a community-led rare disease ELSI research agenda
-
Published:2024-01-22
Issue:1
Volume:19
Page:
-
ISSN:1750-1172
-
Container-title:Orphanet Journal of Rare Diseases
-
language:en
-
Short-container-title:Orphanet J Rare Dis
Author:
Berrios CourtneyORCID, McBeth Macy, Bradley-Ewing Andrea, Schuetz Nikolaus, Campbell Annette, Talebizadeh Zohreh, Garrett Jeremy R., Falicov Tamara, Martinez Francisco, , Adams Jensen, Akpan Jewel, Baesel-Freund Kelly L., Biyala Urvi, Cramer Emily, Freeman Kimberly, Gallagher Terrence, Jarrar Ada, Jones Linda Vaughn, Lewis Tamorah, Long George, Petersen Nancy, Prout Kerry K., Rosas Alejandro, Strenk Meghan, Wirtz Melissa, Wright S. Margaret, Wood Miller, Wood West, Hurley Emily A.
Abstract
Abstract
Background
Research priorities are best defined through engagement with communities who will be impacted by the research and have lived experience of the topics to be studied. We aimed to establish a pediatric rare disease community stakeholder group and empower them in (1) eliciting perspectives from affected families in the wider region and (2) synthesizing collective ideas into a research agenda focused on shared ethical, legal, and social implications (ELSI) across rare disease.
Methods
This two-year project utilized a community-centered approach to engage rare disease community members as equal partners in developing a research agenda for ELSI in rare disease. We established “Rare Voices” (RV), a 22-member stakeholder group of patients, parents, clinicians and researchers. Following capacity-building trainings, RV designed and conducted listening sessions with teen patients and parents of children with rare diseases to explore challenges, positive experiences, and ethical concerns. Listening session findings were synthesized and contextualized into research topics, which RV members further refined and prioritized. We used established measures to assess RV member engagement and satisfaction.
Results
From 14 listening sessions with parents (n = 52) and teen patients (n = 13), RV identified eight core research topics as most important for future rare disease research: coordinating care, communication, accessing resources and care, impact on family unit, community and support in society, mental health and identity, ethical aspects of care, and uncertainty. RV members were highly engaged throughout the two-year project and reported high levels of satisfaction with the experience and research agenda.
Conclusions
Through capacity-building and authentic engagement, this project resulted in a community-led rare disease research agenda to guide future rare disease ELSI research that aligns with patients’ and families’ priorities. An environment of equal partnership and respect created a space for mutual learning where community members were empowered to shape the research agenda based on their collective experiences. The agenda recognizes the shared psychosocial and healthcare experiences of rare disease and offers practical areas of research to address patient and family needs.
Funder
Patient-Centered Outcomes Research Institute Genomic Answers for Kids
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Caldwell WB, Reyes AG, Rowe Z, Weinert J, Israel BA. Community partner perspectives on benefits, challenges, facilitating factors, and lessons learned from community-based participatory research partnerships in Detroit. Prog Community Health Partnersh. 2015;9(2):299–311. 2. Shen S, Doyle-Thomas KAR, Beesley L, Karmali A, WilliamsL, Tanel N, McPherson AC. How and why should we engage parents as co-researchers in health research? A scoping review of current practices. Health Expectations.2017;20(4):543–554. 3. Sprague Martinez L, Carolan K, O’Donnell A, Diaz Y, Freeman ER. Community engagement in patient-centered outcomes research: Benefits, barriers, and measurement. Journal of Clinical and Transational Science. 2018;2(6):371–6. 4. Merkel PA, Manion M, Gopal-Srivastava R, Groft S, Jinnah HA, Robertson D, et al. The partnership of patient advocacy groups and clinical investigators in the rare diseases clinical research network. Orphanet J Rare Dis. 2016;11:66. 5. Ainsworth C. Rare diseases band together toward change in research. Nat Med. 2020;26(10):1496–9.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|